Search Results for "Abbott Dartford Murex Biotech Ltd"

06:52 EDT 31st August 2015 | BioPortfolio

Matching Channels

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Abbott Laboratories To Vote In Favor Of Myan's Takeover Bid For Perrigo

CANONSBURG (dpa-AFX) - Abbott Laboratories (ABT), the largest shareholder of generic drug maker Mylan N.V. (MYL), on Tuesday confirmed its continued support for Mylan's growth strategy. Abbott als...

Abbott Declares 366th Consecutive Quarterly Dividend

ABBOTT PARK, Ill., June 12, 2015 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 24 cents per share. This marks the 366th consecutive q...

Teva Buying Mylan? “Not Likely,” Abbott CEO Says

Abbott CEO Miles White stands by his assertion that a combination between Mylan and OTC drug maker Perrigo makes more strategic sense than a combination between Myaln and Teva. Abbott is Mylan’s lar...

Abbott to table $25bn bid for medical device maker St Jude

Abbott Laboratories is preparing a $25 million takeover bid for medical device maker St Jude Medical.  Illinois-based Abbott has been advised by JPMorgan and Citi for several weeks, and prep...

BRIEF-Abbott announces two Mitral valve transactions

* Abbott says will acquire the equity of Tendyne that it does not already own for $225 million upfront

Abbott to table $25bn bid for medical device maker St Jude?

Abbott Laboratories is said to be preparing a $25 billion takeover bid for medical device maker St Jude Medical.  Illinois-based Abbott has been advised by JPMorgan and Citi for several week...

Abbott Hosts Conference Call for Second-Quarter Earnings

ABBOTT PARK, Ill., July 1, 2015 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its second-quarter 2015 financial results on Wednesday, July 22, 2015, before the market opens.  The announ...

Nursing director concerned at high number of patient falls

Dartford and Gravesham NHS Trust plans to bring in low rise beds and visual aids for older people to prevent people sustaining injuries through falls.

Matching PubMed Articles

Evaluation of Copan FLOQSwab for the molecular detection of Chlamydia trachomatis by Abbott RealTime CT PCR.

We evaluated Copan FLOQSwabs next to Abbott swabs for the detection of Chlamydia trachomatis (CT) by Abbott RealTime PCR.

Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens.

The automated high-throughput Abbott RealTime MTB real-time PCR assay has been recently launched for Mycobacterium tuberculosis complex (MTBC) clinical diagnosis. This study would like to evaluate its...

CLSI-based Transference of CALIPER Pediatric Reference Intervals to Beckman Coulter AU Biochemical Assays.

The CALIPER program has established a comprehensive database of pediatric reference intervals using largely the Abbott ARCHITECT biochemical assays. To expand clinical application of CALIPER reference...

Old boy biotech.

Bridging tech and biotech.

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement